Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,142
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 15,021–15,040 of 17,335 recalls

FDA Recall Terminated Historical recordClass I

Sinai Hospital (MD) TPN Neonatal Day 1 Bag, Trophamine 10 g, Dextrose 25 g, Additives: Calcium Gluconate 1500 mg, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Holy Cross Hospital (MD) AA3%TPN Neonatal Day 1 Bag, Trophamine 10%/3% Dextrose 70%/10%, Additives: Calcium Gluconate 0.46 mEq/mL, 5mEq, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Olathe Medical Center (KS) NICU TPN Starter: Ingredients per 80 ml, Trophamine 3g Dextrose 10%, Additives: Calcium Gluconate 250mg, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Methodist Hospital Northlake (IN) Neo Starter TPN D5, AA2, Trophamine 2% Dextrose 5%, Additives: heparin PF 100 units/mL, 50 units/dL, Calcium Gluconate 0.46 mEq/mL, 200 mg/dL, compound vol: 300 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Advocate Good Samaritan Hospital (IL) TPN Dextrose 10% Trophamine 2%, Trophamine 2% Dextrose 10%, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Advocate Good Samaritan Hospital (IL) TPN Dextrose 5% Trophamine 2%, Trophamine 5% Dextrose 2%, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Adventist Hinsdale Hospital (IL) Neonatal Starter: Troph 2% Dex10%, Trophamine 2% Dextrose 10%, Additives: heparin PF 0.5 unit(s)/ml, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Adventist Hinsdale Hospital (IL) Neonatal Starter: Troph 4%Dex5% ,Trophamine 4% Dextrose 5%, Additives: heparin PF 0.5 unit(s)/ml, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Bridgeport Hospital (CT)TPN Neonatal Standard Solution, Trophamine 6% Dextrose 10%, Additives: heparin PF 0.5 unit(s)/ml, Calcium Gluconate 4mEq/L, compound vol: 150 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

The Medical Center of Aurora (CO) Neonate Starter 2% AA/D10W, Trophamine 2% Dextrose 10%, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Rose Medical Center (CO) Neonate D5 Bridge, Trophamine 3% Dextrose 5%, Additives: heparin PF 0.5 unit(s)/ml, compound vol: 350 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Rose Medical Center (CO) Neonate D10 Bridge, Trophamine 3% Dextrose 10%, Additives: heparin PF 0.5 unit(s)/ml, compound vol: 350 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Children's Hospital Colorado Springs TPN Neonate Starter Bag 4% AA/10% DEX, Trophamine 4% Dextrose 10%, compound vol: 500 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

University of Alabama Birmingham TPN Neonatal Starter Bag, compound vol: 100 ml, Trophamine 4% Dextrose 10%, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box. each container is lined with a polystyrene insert; CAPS, Allentown, PA

by Central Admixture Pharmacy Services, Inc.

Reason
Non-Sterility: Out of specification results for the sterility test for microbial contamination.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49

by Hospira Inc.

Reason
Crystallization
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49

by Hospira Inc.

Reason
Crystallization
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724, NDC: 23155-116-01.

by Heritage Pharmaceuticals, Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fexofenadine HCl Tablets, USP, 60 mg, Allergy, Antihistamine, Indoor and Outdoor Allergies, Non-Drowsy, Original Prescription Strength, a) 60 count Bottles, NDC 0378-0781-91, b) 500 count Bottles, NDC 0378-0781-05, Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, USA.

by Mylan Pharmaceuticals Inc.

Reason
Failed Impurities/Degradation Specifications: out of specification results for a related compound - a degradant of fexofenadine.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

MitoXANTRONE Injection, USP, (concentrate) 2 mg/mL, Rx Only. Hospira, Lake Forest, IL 60045, Product of Australia. Available in a) 20 mg/10 mL Multi Dose Vial (NDC: 61703-343-18); b) 25 mg/12.5 mL Multi Dose Vial (NDC: 61703-343-65); c) 30 mg/15 mL Multi Dose Vial (NDC: 61703-343-66).

by Hospira Inc.

Reason
Failed Stability Specifications: Product is subpotent and has out of specification known and unknown impurities.
Published
April 15, 2015
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fomepizole Injection, 1.5 g/1.5 mL (1 g/mL), For Intravenous Infusion only, Rx only, Manufactured by: Emcure Pharmaceuticals Lt. for Sandoz Inc., Princeton, NJ 08540, NDC 0781-3182-73 and 0781-3182-84

by Navinta LLC

Reason
Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.
Published
April 15, 2015
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.